Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation

Cancer Clinical Trial

— ASK  

Official title:

Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02541266
• Other study ID #: 15 LO 1189
• Status: Completed
• Start date: April 1, 2015
• Est. completion date: August 1, 2018

Study information

• Verified date: January 2020
• Source: Institute of Cancer Research, United Kingdom
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This research is aimed at finding out what may influence the decision of patients to participate in trials involving imaging so that the investigators may improve our future studies so they are more patient focused and acceptable in regards to scan schedules.

Description:

This is a questionnaire study aimed at gaining a greater understanding of the patient perspective on undertaking imaging procedures, MRI and PET/CT, for research purposes. The study is to evaluate the patient opinion and perceptions of the burden of imaging associated with research. We will look at different scanning procedures of varying duration, intensity, frequency and scheduling; this will enable us to have a better understand of the factors that influence participation in research and thus help us develop protocols that are more patient focused and acceptable.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 207
• Est. completion date: August 1, 2018
• Est. primary completion date: August 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria

• Being treated at The Royal Marsden Hospital

• Over the age of 18

• Having imaging (MRI or PET/CT) as part of research or clinical care.

• Group 1

• Currently enrolled in a research project that involves imaging (either MRI or PET/CT)

• Group 2

• Previously enrolled in a research project that involved imaging (either MRI or PET/CT), where the patients involvement in the research project has now ended.

• Group 3

• Patients attending the MRI or PET/CT departments for imaging as part of their standard clinical care.

Exclusion Criteria -

• Inability to complete the questionnaire.

• Previously completed questionnaire.

Related Conditions & MeSH terms

• Cancer

Intervention

Other:
• Questionnaire
A short questionnaire (9 questions) will be given to the participants to complete.

Locations

Country	Name	City	State
United Kingdom	The Royal Marsden NHS Foundation Trust	Sutton	Surrey

Sponsors (3)

Lead Sponsor	Collaborator
Institute of Cancer Research, United Kingdom	National Institute for Health Research, United Kingdom, Royal Marsden NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Factors that affect patient participation in imaging research	Factors about an imaging scan - type, length, frequency or scheduling (timing in relation to treatment) - that are perceived as a significant burden when considering participation in a research study involving imaging.	Duration of Study - 1 year
Secondary	Factors affecting participation in the different patient categories		Duration of Study - 1 year
Secondary	Effect of current participation in a study on the perceived acceptability of imaging burden		Duration of Study - 1 year
Secondary	Do opinions change after undergoing imaging procedures		Duration of Study - 1 year